High-Throughput Compound Screening Identifies Navitoclax Combined with Irradiation as a Candidate Therapy for HPV-Negative Head and Neck Squamous Cell Carcinoma

Scientists ran an assay using five human papillomavirus (HPV)-negative head and neck squamous cell carcinoma cell lines cultured on the human tumor-derived matrix Myogel.